Trade Summary

4 days ago, Liptak Vincent Paul, serving as General Counsel at BlossomHill Therapeutics, Inc. (BLSM), purchased 4,700 shares at $15.89 per share, for a total transaction value of $74,700.00. Following this transaction, Liptak Vincent Paul now holds 111,412 shares of BLSM.

This purchase represents a 4.40% increase in Liptak Vincent Paul's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 6:26 PM ET, 3 days after the trade was made.

BlossomHill Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.